Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cannabinoid receptor 2 (macrophage) | Starlite/ChEMBL | References |
Homo sapiens | cannabinoid receptor 1 (brain) | Starlite/ChEMBL | References |
Homo sapiens | diacylglycerol lipase, alpha | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | lipase | 0.0173 | 0.7076 | 0.7076 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0.0318 | 0.5 |
Brugia malayi | Lipase family protein | 0.0173 | 0.7076 | 0.7076 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0.0318 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0173 | 0.7076 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0.0318 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0173 | 0.7076 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0.0318 | 0.5 |
Trypanosoma brucei | lipase domain protein, putative | 0.0173 | 0.7076 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0049 | 0.1658 | 0.1658 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.024 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0318 | 0.1916 |
Onchocerca volvulus | 0.0173 | 0.7076 | 1 | |
Echinococcus granulosus | sn1 specific diacylglycerol lipase beta | 0.0173 | 0.7076 | 0.7076 |
Trichomonas vaginalis | lipase containing protein, putative | 0.0173 | 0.7076 | 1 |
Onchocerca volvulus | 0.0049 | 0.1658 | 0.2343 | |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0018 | 0.0318 | 0.0318 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0.0318 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.024 | 1 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0018 | 0.0318 | 0.0318 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0.0318 | 0.5 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0318 | 0.5 |
Trypanosoma brucei | lipase domain protein, putative | 0.0173 | 0.7076 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.1658 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0.0318 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0173 | 0.7076 | 1 |
Echinococcus multilocularis | sn1 specific diacylglycerol lipase beta | 0.0173 | 0.7076 | 0.7076 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0018 | 0.0318 | 0.0318 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0018 | 0.0318 | 0.0318 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0318 | 0.1916 |
Trichomonas vaginalis | lipase containing protein, putative | 0.0173 | 0.7076 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0049 | 0.1658 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0318 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.1 uM | Inhibition of human recombinant DAGL-alpha-mediated sn-1-[14C]oleoyl-2-arachidonoyl-glycerol hydrolysis to 2-AG overexpressed in african green monkey COS7 cell membrane by scintillation counting | ChEMBL. | 18831576 |
IC50 (binding) | > 50 uM | Inhibition of FAAH-mediated [14C]anandamide hydrolysis in rat brain membrane | ChEMBL. | 18831576 |
Ki (binding) | = 2.6 uM | Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK293 cells by scintillation counting | ChEMBL. | 18831576 |
Ki (binding) | > 10 uM | Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in HEK293 cells by scintillation counting | ChEMBL. | 18831576 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.